Amphenol Corporation (APH) earnings on July 29, 2026
More Amphenol Corporation earnings
Prior outlook: Optimistic Outcome: Accurate
Amphenol shares surged after quarterly results substantially beat profit and sales estimates.
APH price around the earnings
150.31
Change: +4.5%
2026-07-29, 20:00 UTC
Start of the measured window
End of the measured window
142.43
147.53
152.62
157.72
143.85
July 29, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- Starting price
Prior thesis
Prior outlook: Optimistic Outcome: Accurate
- Thesis published
- Results released
Strong analyst 'Buy' consensus and strong recent earnings history contrast with recent negative trend strength and sector selloff.
Context analyzed before publication
- Trend
- The stock experienced a significant selloff, reaching a state after a strong recent drop, followed by a strong and rapid rebound into earnings.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.56
- Analysts covering the stock
- 18
- Average price target
- 189.39
- Lowest price target
- 165
- Highest price target
- 215
- Upside to price target
- 31.7%
- Quarterly earnings growth
- 26.5%
- Revenue growth
- 58.4%
- Forward EPS
- 5.85
- Trailing EPS
- 3.35
- Analyst moves in the last 60 days
- 5
- Strong buy: 4
- Buy: 11
- Hold: 3
- Sell: 0
- Strong sell: 0
- Strong buy
- 4
- Buy
- 11
- Hold
- 3
- Sell
- 0
- Strong sell
- 0
- July 13, 2026 · TD Cowen: Maintains rating (Hold → Hold)
- July 13, 2026 · Citigroup: Maintains rating (Buy → Buy)
- July 13, 2026 · Barclays: Maintains rating (Overweight → Overweight)
- July 9, 2026 · UBS: Maintains rating (Buy → Buy)
- July 9, 2026 · B of A Securities: Maintains rating (Buy → Buy)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (7)
- Here's How Much $100 Invested In Amphenol 5 Years Ago Would Be Worth Today (opens in a new tab) — Benzinga
- TD Cowen Maintains Hold on Amphenol, Raises Price Target to $175 (opens in a new tab) — Benzinga
- Citigroup Maintains Buy on Amphenol, Raises Price Target to $195 (opens in a new tab) — Benzinga
- Barclays Maintains Overweight on Amphenol, Raises Price Target to $200 (opens in a new tab) — Benzinga
- UBS Maintains Buy on Amphenol, Raises Price Target to $185 (opens in a new tab) — Benzinga
- B of A Securities Maintains Buy on Amphenol, Raises Price Target to $185 (opens in a new tab) — Benzinga
- If You Invested $1000 In Amphenol Stock 5 Years Ago, You Would Have This Much Today (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 143.82
- Average true range (ATR)
- 4.7%
- Distance to 52-week high
- -15.3%
- 14-day change (14d)
- -9.2%
- 30-day change (32d)
- -12.0%
- 30-day relative strength
- -13.6%
- SPY change (32d)
- +1.6%
- Nearest support
- 143.6
- Distance to nearest support
- 0.2%
- Nearest resistance
- 145.73
- Distance to nearest resistance
- 1.3%
- Volume accumulation ratio (14d / 46d)
- 0.66
- Major: 143.6 (0.2% away, 0.03 ATR, 28 touches)
- Mid: 142.21 (1.1% away, 0.24 ATR, 13 touches)
- Major: 140.48 (2.3% away, 0.5 ATR, 31 touches)
- Mid: 145.73 (1.3% away, 0.29 ATR, 20 touches)
- Mid: 147.45 (2.5% away, 0.54 ATR, 25 touches)
- Major: 148.87 (3.5% away, 0.75 ATR, 30 touches)
Trends
Evidence
- Average earnings surprise
- +13.3%
- April 29, 2026: actual EPS 1.06 vs estimate 0.95 (surprise +12.0%)
- January 28, 2026: actual EPS 0.97 vs estimate 0.94 (surprise +3.1%)
- October 22, 2025: actual EPS 0.93 vs estimate 0.8 (surprise +16.5%)
- July 23, 2025: actual EPS 0.81 vs estimate 0.67 (surprise +21.7%)
Expected move
- Implied move
- +3.4%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 2.6%
- 75th percentile move
- 5.4%
- 90th percentile move
- 7.1%
- Up / down moves
- 14 / 6
- Average up move
- +3.3%
- Average down move
- -4.1%
Monitoring and close
What Amphenol Corporation reported
- Status
- Finished
| Actual EPS | 1.35 |
|---|---|
| EPS estimate | 1.18 |
| EPS surprise | +14.4% |
| Revenue | $8,758 million |
| Revenue estimate | $8,239 million |
| Revenue surprise | +6.3% |
Amphenol beats Q2 estimates and gives optimistic Q3 guidance. AI demand drives results.
Sources (15)
- Amphenol Corporation (APH) Q2 2026 Earnings Call Transcript (opens in a new tab) — SeekingAlpha
- Here is Why Growth Investors Should Buy Amphenol (APH) Now (opens in a new tab) — Zacks
- Amphenol's Q2 Earnings Beat Estimates, Revenues Rise Y/Y (opens in a new tab) — Zacks
- Amphenol (APH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (opens in a new tab) — Zacks
- Amphenol (APH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (opens in a new tab) — Zacks
- Amphenol Beats Second-Quarter Forecasts as AI Demand Fuels Growth and Outlook Improves (opens in a new tab) — InvestorsHub
- Amphenol (NYSE:APH) Soars on Q2 Earnings Beat and Bullish Guidance (opens in a new tab) — ChartMill
- Amphenol (APH) Beats Q2 Earnings and Revenue Estimates (opens in a new tab) — Zacks
- Amphenol beats Q2 estimates, raises Q3 outlook on AI-driven demand (opens in a new tab) — Investing.com
- Amphenol (NYSE:APH) Surprises With Strong Q2 CY2026, Stock Soars (opens in a new tab) — StockStory
- Amphenol reported adjusted EPS of $1.35, beating the $1.18 estimate, and revenue of $8.758B, above the $8.239B forecast. — Benzinga
- Amphenol Q2 Adj. EPS $1.35 Beats $1.18 Estimate, Sales $8.758B Beat $8.239B Estimate (opens in a new tab) — Benzinga
- Amphenol Q2 Adj. EPS $1.35 Up From $0.81 YoY, Sales $8.758B Up From $5.650B YoY (opens in a new tab) — Benzinga
- Amphenol Sees Q3 Adj EPS $1.40-$1.42 vs $1.27 Est; Sees Sales $9.300B-$9.400B vs $8.683B Est (opens in a new tab) — Benzinga
- Amphenol Reports Record Second Quarter 2026 Results (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, the figures confirm the optimistic scenario. In the 1038 past cases with a similar move, the close held that direction 96% of the time.
How the stock reacted
- Outcome
- Accurate
- Consolidated
- +4.5%
- Max favorable move (MFE)
- 10.6%
- Max adverse move (MAE)
- 1.8%